This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1999 Spring;39(2):107-24.

doi: 10.1097/00004397-199903920-00009.

Adverse events associated with commonly used glaucoma drugs

R Vogel¹, E Strahlman, K D Rittenhouse

Affiliations

PMID: 10343928
DOI: 10.1097/00004397-199903920-00009

Review

Adverse events associated with commonly used glaucoma drugs

R Vogel et al. Int Ophthalmol Clin. 1999 Spring.

. 1999 Spring;39(2):107-24.

doi: 10.1097/00004397-199903920-00009.

Authors

R Vogel¹, E Strahlman, K D Rittenhouse

Affiliation

¹ Clinicor, Inc., Austin, TX 78703, USA.

PMID: 10343928
DOI: 10.1097/00004397-199903920-00009

No abstract available

PubMed Disclaimer

Similar articles

Controversies in Glaucoma: Current Medical Treatment and Drug Development.
Bucolo C, Platania CB, Reibaldi M, Bonfiglio V, Longo A, Salomone S, Drago F. Bucolo C, et al. Curr Pharm Des. 2015;21(32):4673-81. doi: 10.2174/1381612821666150909095553. Curr Pharm Des. 2015. PMID: 26350532 Review.
[Ocular side effects of glaucoma treatment agents].
Ehongo A, Bremer F. Ehongo A, et al. Bull Soc Belge Ophtalmol. 2007;(304):103-10. Bull Soc Belge Ophtalmol. 2007. PMID: 17718234 Review. French.
Pharmacological therapy for glaucoma: a review.
Hoyng PF, van Beek LM. Hoyng PF, et al. Drugs. 2000 Mar;59(3):411-34. doi: 10.2165/00003495-200059030-00003. Drugs. 2000. PMID: 10776828 Review.
Ocular therapeutics.
Jeglum EL. Jeglum EL. Nurs Clin North Am. 1981;16(3):453-77. Nurs Clin North Am. 1981. PMID: 6117832 No abstract available.
A topical prostaglandin for glaucoma.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 1996 Nov 8;38(987):100-1. Med Lett Drugs Ther. 1996. PMID: 8914508 No abstract available.

See all similar articles

Cited by

Topical prostaglandin analogue drugs inhibit adipocyte differentiation.
Kim JW. Kim JW. Korean J Ophthalmol. 2014 Jun;28(3):257-64. doi: 10.3341/kjo.2014.28.3.257. Epub 2014 May 19. Korean J Ophthalmol. 2014. PMID: 24882960 Free PMC article.
In vitro study of antiadipogenic profile of latanoprost, travoprost, bimatoprost, and tafluprost in human orbital preadiopocytes.
Choi HY, Lee JE, Lee JW, Park HJ, Lee JE, Jung JH. Choi HY, et al. J Ocul Pharmacol Ther. 2012 Apr;28(2):146-52. doi: 10.1089/jop.2011.0160. Epub 2011 Nov 22. J Ocul Pharmacol Ther. 2012. PMID: 22107041 Free PMC article.
Brinzolamide : a review of its use in the management of primary open-angle glaucoma and ocular hypertension.
Cvetkovic RS, Perry CM. Cvetkovic RS, et al. Drugs Aging. 2003;20(12):919-47. doi: 10.2165/00002512-200320120-00008. Drugs Aging. 2003. PMID: 14565787 Review.
Changes to upper eyelid orbital fat from use of topical bimatoprost, travoprost, and latanoprost.
Park J, Cho HK, Moon JI. Park J, et al. Jpn J Ophthalmol. 2011 Jan;55(1):22-7. doi: 10.1007/s10384-010-0904-z. Epub 2011 Feb 18. Jpn J Ophthalmol. 2011. PMID: 21331688

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information